88IV - PR Newswire Asia's news


AI-driven Molecular Glue Innovation: Insilico Nominates ISM9546, an Oral, Peripheral-Restricted VAV1 Degrader as PCC for Autoimmune Diseases Sustained Boost in AI-Driven R&D Productivity : ISM9546 marks Insilico Medicine's 35th preclinical candidate (PCC) nominated since 2021 and its 11th PCC within the first 10 months of 2026 alone, setting ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of demand for Waters' instruments and consumables ... 2026-10-13T Biotechnology Computer Software Computer/Electronics Health Care/Hospital
Ailux Appoints Lloyd S. Miller, M.D., Ph.D., as Chief Medical Officer Dr. Miller will lead the advancement of the company's AI-native biologics toward first-in-human trials, with initial clinical entry targeted for 2027 He will also establish a U.S. clinical and research ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech to Present Multiple Study Results at ESMO 2026 CHENGDU, China , Oct. 13, 2026 /PRNewswire/ -- The 2026 European Society for Medical Oncology (ESMO) Congress will be held in Madrid, Spain, from October 23 to 27. Sichuan Kelun-Biotech Biopharmaceutical ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China Hiteck grants Visara, a majority-owned ophthalmology subsidiary of NovaBridge Biosciences (NASDAQ: NBP), exclusive worldwide rights, excluding Greater China, to develop and commercialize HT006.2.2 ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Rona Therapeutics enters into global license agreement with Roche for ALK7-targeting RNAi therapy for obesity and metabolic diseases SANTA BARBARA, Calif. , Oct. 13, 2026 /PRNewswire/ -- Rona Therapeutics today announced it has granted Roche (SIX: RO, ROG; OTCQX: RHHBY) an exclusive worldwide license for Rona's investigational RNAi ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention SHANGHAI , Oct. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has granted its investigational ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration Linking North American and Asia-Pacific Capabilities to Support Joint Sales and Project Execution ... 2026-10-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research Collaboration expands access to Lunit's AI-powered pathology platform by combining it with Discovery Life Sciences' global biospecimen and specialty laboratory capabilities, enabling standardized tissue ... 2026-10-12T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
T-MAXIMUM's B7-H3-Targeted Allogeneic CAR-T MT027 Receives FDA Clearance for Phase 2 Study in Brain Metastases from Lung and Breast Cancer BEIJING , Oct. 12, 2026 /PRNewswire/ -- T-MAXIMUM PHARMACEUTICAL ("T-MAXIMUM") today announced that the U.S. Food and Drug Administration (FDA) has cleared the company to initiate a Phase ... 2026-10-12T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology